Example: Heart Attack

Clinical Trials on Neoplasms, Connective and Soft Tissue

Total 2628 results

NCT01883518

Enrolling by invitation

Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma

Conditions: Sarcoma; Neoplasms, Connective and Soft Tissue
NCT02677961

Recruiting

An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry

Conditions: Neoplasms, Connective and Soft Tissue; Bone Neoplasms
NCT01491594

Terminated

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Conditions: Sarcoma, Soft Tissue; Osteosarcoma; Neoplasms, Connective and Soft Tissue
NCT03539172

Unknown status

Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS Study

Conditions: Soft Tissue and Bone Tumor; Head and Neck Cancer; Sarcoma
NCT02199938

Terminated

Identification and Characterization of Molecular Markers in Musculoskeletal Tumors

Conditions: Soft Tissue and Bone Tumors; Sarcoma; Sarcoma of Bone; Soft Tissue Sarcoma
NCT00102609

Completed

A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma

Conditions: Soft Tissue Sarcoma; Sarcoma; Neoplasms, Connective and Soft Tissue; Neoplasms by Histologic Type; Neoplasms
NCT00180947

Unknown status

Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse

Conditions: Rhabdomyosarcomas; Neoplasms, Connective and Soft Tissue; Ewing Tumor; Osteosarcomas; Neuroblastomas; Medulloblastomas
NCT04185883

Recruiting

AMG 510 (pINN) Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Conditions: Advanced Solid Tumors; Kirsten Rat Sarcoma (KRAS) pG12C Mutation
NCT03240861

Recruiting

Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer

Conditions: HLA-A*0201 Positive Cells Present; Locally Advanced Malignant Neoplasm; NY-ESO-1 Positive; Unresectable Malignant Neoplasm; Sarcoma
NCT00927966

Completed

RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms

Conditions: Sarcoma; Solid Tumor
NCT01417546

Active, not recruiting

NHS-IL12 for Solid Tumors

Conditions: Epithelial Neoplasms, Malignant; Epithelial Tumors, Malignant; Malignant Mesenchymal Tumor
NCT03818412

Recruiting

Circulating Tumor DNA in Soft Tissue Sarcoma

Conditions: Soft Tissue Sarcoma
NCT03495921

Active, not recruiting

Vigil + Irinotecan and Temozolomide in Ewing's Sarcoma

Conditions: Ewing Sarcoma; Ewing Family of Tumors; Ewing's Tumor Metastatic; Ewing's Sarcoma Metastatic; Ewing's Tumor Recurrent; Rare Diseases; Sarcoma; Neoplasms, Connective and Soft Tissue; Neoplasms by Histologic Type; Neoplasms, Bone Tissue; Neoplasms, Connective Tissue; Sarcoma, Ewing; Neoplasms
NCT03056599

Recruiting

Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma

Conditions: Soft Tissue Sarcoma Adult
NCT03798795

Completed

Radiomics for Tumor Grading of Soft Tissue Sarcomas.

Conditions: Sarcoma, Soft Tissue
NCT04733183

Recruiting

Efficacy and Safety of L19TNF in Previously Treated Patients With Advanced Stage or Metastatic Soft-tissue Sarcoma

Conditions: Soft Tissue Sarcoma
NCT04318964

Recruiting

TAEST16001 in the Treatment of Soft Tissue Sarcoma

Conditions: Soft Tissue Sarcoma
NCT04650984

Recruiting

A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma

Conditions: Soft Tissue Sarcoma
NCT01575951

Completed

Pilot Study: Dynamic Contrast-enhanced Magnetic Resonance Imaging(DCE-MRI)for Assessing Tumor Vascularity and Permeability in Soft Tissue Sarcoma Treated With Preoperative Radiotherapy Followed by Surgical Resection

Conditions: Soft Tissue Sarcoma
NCT04095208

Recruiting

Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study

Conditions: Soft Tissue Sarcoma Adult; Advanced Cancer
NCT03104335

Withdrawn

Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial

Conditions: Soft Tissue Sarcoma Adult; Advanced Cancer
NCT03985722

Recruiting

Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma Patients

Conditions: Sarcoma, Soft Tissue
NCT03838744

Recruiting

Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments.

Conditions: Advanced Soft Tissue Sarcoma
NCT04288375

Recruiting

Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs

Conditions: Soft Tissue Sarcoma
NCT04307277

Recruiting

Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Grade 1 or 2 Soft Tissue Sarcoma

Conditions: Soft Tissue Sarcoma